References
- Hazenberg BP. Amyloidosis: a clinical overview. Rheum Dis Clin North Am. 2013;39:323–345.
- Berk JL. Pulmonary and tracheobronchial involvement with amyloidosis. In: Lynch I, Joseph P, editors. Interstitial pulmonary and bronchiolar disorders. New York (NY): Informa Healthcare USA Inc.; 2008. p. 789–807.
- Smith RR, Hutchins GM, Moore GW, Humphrey RL. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid. Am J Med. 1979;66:96–104.
- Seldin DC, Skinner M. Amyloidosis. In: Ruddy S, Harris ED, Sledge C, editors. Kelley’s textbook of rheumatology. Philadelphia (PA): Elsevier; 2005. p. 1697–1704.
- Berk JL, O’Regan A, Skinner M. Pulmonary and tracheobronchial amyloidosis. Semin Respir Crit Care Med. 2002;23:155–165.
- Celli BR, Rubinow A, Cohen AS, Brody JS. Patterns of pulmonary involvement in systemic amyloidosis. Chest. 1978;74:543–547.
- Westermark P, Bergstrom J, Solomon A, et al. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid. 2003;10:48–54.
- Ueda M, Ando Y, Haraoka K, et al. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis. Amyloid. 2006;13:24–30.
- Kline LR, Dise CA, Ferro TJ, Hansen-Flaschen JH. Diagnosis of pulmonary amyloidosis by transbronchial biopsy. Am Rev Respir Dis. 1985;132:191–194.
- Strange C, Heffner JE, Collins BS, et al. Pulmonary hemorrhage and air embolism complicating transbronchial biopsy in pulmonary amyloidosis. Chest. 1987;92:367–369.
- Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18–22 April 2004. Am J Hematol. 2005;79:319–328.
- Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720–735.
- Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338.
- Dubois AB, Botelho SY, Bedell GN, et al. A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest. 1956;35:322–326.
- Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968.
- Yood RA, Skinner M, Rubinow A, et al. Bleeding manifestations in 100 patients with amyloidosis. JAMA. 1983;249:1322–1324.
- Cibeira MT, Sanchorawala V, Seldin DC, et al. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011;118:4346–4352.
- Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann Intern Med. 1996;124:407–413.
- Kunze WP. Senile pulmonary amyloidosis. Pathol Res Pract. 1979;164:413–422.
- Pitkanen P, Westermark P, Cornwell GG III. Senile systemic amyloidosis. Am J Pathol. 1984;117:391–399.
- Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc. 1984;59:547–555.